BioLoomics Appoints Kurt Gish as Chief Scientific Officer to Advance Development of Improved ADCs [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
BOULDER, Colo., June 13, 2024 BUSINESS WIRE BioLoomics , a biotechnology company that targets peptide-antibody chimeras to specific compartments inside of diseased cells, announced today that Kurt Gish, Ph.D., has joined as the Chief Scientific Officer. Dr Gish will focus on building the company's pipeline of lysosomal targeting ADCs in oncology to overcome the limitations of poor tumor uptake, which hinders safety and efficacy across the ADC market. "Kurt is an impressive and accomplished scientist that sits at the intersection of ADCs, peptides, and target discovery/validation. He has a deep understanding of how improper spatial targeting of ADCs has limited the field. With his deep experience in the ADC space, I am confident that Kurt will be invaluable to advancing BioLoomics's technology to build safer and more efficacious ADCs for both strategic partners and internal programs." - Dr. Chapnick, CEO and Founder of BioLoomics. Prior to BioLoomics, Dr. Gish served as Chief Scie
Show less
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- Direct Relief Announces Appointment of Three Directors to Board [Yahoo! Finance]Yahoo! Finance
- AbbVie Declares Quarterly DividendPR Newswire
- Top 10 Companies Dominating the Global Drug Delivery Systems Market [Yahoo! Finance]Yahoo! Finance
- Cosmetic Surgery and Procedure Devices Market size is set to grow by USD 7.95 billion from 2024-2028, Growing incidence of medical conditions that require cosmetic procedures boost the market, Technavio [Yahoo! Finance]Yahoo! Finance
- MHRA disallows epilepsy drug topiramate use for pregnant patients [Yahoo! Finance]Yahoo! Finance
ABBV
Earnings
- 4/26/24 - Miss
ABBV
Sec Filings
- 6/3/24 - Form 25-NSE
- 5/31/24 - Form SD
- 5/17/24 - Form 25-NSE
- ABBV's page on the SEC website